Epinephrine and Norepinephrine Act as Potent Agonists at the Recombinant Human Dopamine D4 ReceptorF Lanau, Deborah Hartman, Marie‐Thérèse Zenner et al.|Journal of Neurochemistry|1997Cited by 125
Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative ColitisDeborah Hartman, Barbara S. Fox, Daniel E. Tracey et al.|Journal of Crohn s and Colitis|2016Cited by 33
Dopamine receptor diversity: Molecular and pharmacological perspectivesDeborah Hartman, Olivier Civelli|Birkhäuser Basel eBooks|1997Cited by 30
Molecular Attributes of Dopamine Receptors: New Potential for Antipsychotic Drug DevelopmentDeborah Hartman, Olivier Civelli|Annals of Medicine|1996Cited by 26
Expression and characterization of a dopamine D4R variant associated with delusional disorderMarie‐Thérèse Zenner, Marco Catalano, Maria Nobile et al.|FEBS Letters|1998Cited by 19